Vir Biotechnology shareholders elect Class II directors, approve advisory compensation, ratify EY

Vir Biotechnology, Inc.

Directors De Backer, Bischofberger, Farid, Nelsen elected with votes for/withheld: 105.6M/1.1M, 80.0M/26.7M, 106.4M/0.3M, 67.9M/38.8M; broker non-votes 12.3M.
Advisory vote on executive compensation approved: 83.9M for, 22.6M against, 0.2M abstain; broker non-votes 12.3M.
Ratification of Ernst & Young as auditor: 118.1M for, 679,046 against, 168,971 abstain; no broker non-votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.